Kyorin Pharmaceutical Co Ltd (4569) Stock Price & News

4569:TYO

Kyorin Pharmaceutical Co Ltd

¥1,142.00

-5.70%

(-69.00) 1D

Jul 31, 3:30:00 PM GMT+9 · JPY

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Last report

Jul 30, 2026

Fiscal period

Q1 2027

EPS / Est. (JPY)

- / -

Revenue / Est. (JPY)

29.65B / -

Fiscal Q1 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in JPY

Loading Previous Earnings...

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	28.50B	33.72B	33.80B	29.65B
Cost of goods sold	16.87B	19.09B	21.71B	17.48B
Cost of revenue	16.87B	19.09B	21.71B	17.48B
Research and development expenses	-	-	12.06B	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12.64B	11.39B	1.07B	11.21B
Operating expense	12.69B	11.39B	13.13B	11.21B
Total operating expenses	29.56B	30.48B	34.84B	28.69B
Operating income	-1.06B	3.24B	-1.04B	966.00M
Other non operating income	11.00M	12.00M	13.00M	13.00M
EBT including unusual items	-699.00M	3.49B	-1.07B	1.19B
EBT excluding unusual items	-1.04B	3.51B	-1.07B	1.24B
Income tax expense	-93.00M	869.00M	-402.00M	363.00M
Effective tax rate	13.30%	24.87%	37.47%	30.58%
Other operating expenses	-	-	-	-
Net income	-606.00M	2.62B	-671.00M	824.00M
Net profit margin	-2.13%	7.78%	-1.99%	2.78%
Earnings per share	-	-	-	-
Interest and investment income	38.00M	235.00M	12.00M	-
Interest expense	-61.00M	-59.00M	-70.00M	-
Net interest expenses	-23.00M	176.00M	-58.00M	-
Depreciation and amortization charges	3.00M	3.00M	2.00M	-
EBITDA	82.00M	4.39B	121.75M	2.13B
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance